Skip to main content
. 2019 Oct 11;36(11):2237–2244. doi: 10.1007/s10815-019-01573-z

Table 3.

Combination analysis of miR-146a C > G, miR-149 T > C, miR-196a2 T > C, and miR-499 A > G polymorphisms in the case and control subjects

Genotypes Cases (n = 120) (%) Controls (n = 90) (%) p valuea OR (95% CI)
miR-146a/miR-149
  CC/TT 45 (37.50) 27 (30.00) 0.304 1.400 (0.782–2.508)
  CC/TC 34 (28.33) 17 (18.88) 0.143 1.698 (0.877–3.286)
  CC/CC 2 (1.66) 1 (1.11) 1.000 1.508 (0.135–16.89)
  CG/TT 23 (19.16) 38 (42.22) 0.0001 0.324 (0.175–0.602)
  CG/TC 12 (10.00) 4 (4.44) 0.189 2.389 (0.744–7.670)
  CG/CC 0 (0.00) 0 (0.00) ND ND
  GG/TT 2 (1.66) 3 (3.33) 0.653 0.492 (0.080–3.005)
  GG/TC 2 (1.66) 0 (0.00) 0.508 0.983 (0.961–1.007)
  GG/CC 0 (0.00) 0 (0.00) ND ND
miR-146a/miR-196a2
  CC/TT 60 (50.00) 33 (36.66) 0.068 1.727 (0.988–3.019)
  CC/TC 19 (15.83) 11 (12.22) 0.552 1.351 (0.608–3.003)
  CC/CC 2 (1.66) 1 (1.11) 1.000 1.508 (0.135–16.89)
  CG/TT 26 (21.66) 35 (38.88) 0.009 0.435 (0.237–0.797)
  CG/TC 8 (6.66) 10 (11.11) 0.321 0.571 (0.216–1.512)
  CG/CC 1 (0.83) 0 (0.00) 1.000 0.992 (0.976–1.008)
  GG/TT 3 (2.50) 3 (3.33) 1.000 0.774 (0.147–3.773)
  GG/TC 1 (0.83) 0 (0.00) 1.000 0.992 (0.976–1.008)
  GG/CC 0 (0.00) 0 (0.00) ND ND
miR-146a/miR-499
  CC/AA 11 (9.16) 8 (8.88) 1.000 1.034 (0.398–2.689)
  CC/AG 42 (35.00) 27 (30.00) 0.462 1.256 (0.699–2.259)
  CC/GG 28 (23.33) 10 (11.11) 0.029 2.435 (1.114–5.321)
  CG/AA 4 (3.33) 7 (7.77) 0.212 0.409 (0.116–1.44)
  CG/AG 13 (10.83) 25 (27.77) 0.002 0.316 (0.151–0.661)
  CG/GG 18 (15.00) 13 (14.44) 1.000 1.045 (0.483–2.263)
  GG/AA 1 (0.83) 1 (1.11) 1.000 0.748 (0.046–12.12)
  GG/AG 1 (0.83) 2 (2.22) 0.586 0.370 (0.033–4.412)
  GG/GG 2 (1.66) 0 (0.00) 0.508 0.983 (0.961–1.007)
miR-149/miR-196a2
  TT/TT 53 (44.16) 52 (57.77) 0.070 0.578 (0.333–1.004)
  TT/TC 16 (13.33) 15 (16.66) 0.558 0.769 (0.358–1.652)
  TT/CC 1 (0.83) 1 (1.11) 1.000 0.748 (0.046–12.12)
  TC/TT 34 (28.33) 18 (20.00) 0.197 1.581 (0.824–3.034)
  TC/TC 12 (10.00) 3 (3.33) 0.102 3.222 (0.881–11.77)
  TC/CC 2 (1.66) 0 (0.00) 0.508 0.983 (0.961–1.007)
  CC/TT 2 (1.66) 1 (1.11) 1.000 1.508 (0.135–16.89)
  CC/TC 0 (0.00) 0 (0.00) ND ND
  CC/CC 0 (0.00) 0 (0.00) ND ND
miR-149/miR-499
  TT/AA 8 (6.66) 9 (10.00) 0.447 0.643 (0.238–1.738)
  TT/AG 31 (25.83) 41 (45.55) 0.003 0.416 (0.223–0.745)
  TT/GG 31 (25.83) 18 (20.00) 0.410 1.393 (0.721–2.692)
  TC/AA 7 (5.83) 7 (7.77) 0.598 0.735 (0.248–2.174)
  TC/AG 25 (20.83) 9 (10.00) 0.038 2.368 (1.046–5.364)
  TC/GG 16 (13.33) 5 (5.55) 0.068 2.165 (0.920–7.431)
  CC/AA 1 (0.83) 0 (0.00) 1.000 0.992 (0.976–1.008)
  CC/AG 0 (0.00) 1 (1.11) 0.429 1.011 (0.989–1.034)
  CC/GG 1 (0.83) 0 (0.00) 1.000 0.992 (0.976–1.008)
miR-196a2/miR-499
  TT/AA 12 (10.00) 13 (14.44) 0.391 0.658 (0.285–1.520)
  TT/AG 40 (33.33) 42 (46.66) 0.063 0.571 (0.326–1.002)
  TT/GG 37 (30.83) 16 (17.77) 0.037 2.062 (1.060–4.009)
  TC/AA 3 (2.50) 3 (3.33) 1.000 0.774 (0.147–3.773)
  TC/AG 14 (11.66) 8 (8.88) 0.650 1.354 (0.542–3.381)
  TC/GG 11 (9.16) 7 (7.77) 0.807 1.197 (0.445–3.219)
  CC/AA 1 (0.83) 0 (0.00) 1.000 0.992 (0.976–1.008)
  CC/AG 2 (1.66) 1 (1.11) 1.000 1.508 (0.135–16.89)
  CC/GG 0 (0.00) 0 (0.00) ND ND

OR odds ratio, CI confidence interval, ND not determined

aEvaluated by Fisher’s chi-squared test